+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Haleon Plc (HLN) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 52 Pages
  • August 2024
  • GlobalData
  • ID: 5726051
Haleon Plc (HLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Haleon Plc (Haleon) is a manufacturer of consumer healthcare products. The company’s product range includes over-the-counter (OTC) drugs for respiratory infections, cold and flu, fever, allergy, pain relief, and inflammation, and oral health products such as toothpaste, toothbrushes, and mouthwash. It also offers nasal decongestants, calcium and vitamin-C supplements, and solutions for heartburn, acid indigestion, and gastric discomfort. The company markets its products under Advil, Eno, Tums, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum brand names. It has business presence across the Americas, Europe, the Middle East, Africa, and Asia-Pacific. Haleon is headquartered in Weybridge, England, the UK.

Haleon Plc Key Recent Developments

  • Aug 06, 2024: Haleon Announces Board Changes
  • May 01, 2024: Haleon PLC Announces Directorate Change
  • Apr 24, 2024: Haleon plc: Appointment of Dawn Allen as Chief Financial Officer
  • Feb 29, 2024: Haleon Reports 2023 Full Year Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Haleon Plc - Key Facts
  • Haleon Plc - Key Employees
  • Haleon Plc - Key Employee Biographies
  • Haleon Plc - Major Products and Services
  • Haleon Plc - History
  • Haleon Plc - Company Statement
  • Haleon Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Haleon Plc - Business Description
  • Product Category: Digestive Health and Other
  • Overview
  • Performance
  • Product Category: Oral Health
  • Overview
  • Performance
  • Product Category: Pain Relief
  • Overview
  • Performance
  • Product Category: Respiratory Health
  • Overview
  • Performance
  • Product Category: Vitamins, Minerals and Supplements
  • Overview
  • Performance
  • Geographical Segment: APAC
  • Target Markets
  • Performance
  • Geographical Segment: EMEA and LatAm
  • Target Markets
  • Performance
  • Geographical Segment: North America
  • Target Markets
  • Performance
  • R&D Overview
  • Haleon Plc - Corporate Strategy
  • Haleon Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Haleon Plc - Strengths
  • Haleon Plc - Weaknesses
  • Haleon Plc - Opportunities
  • Haleon Plc - Threats
  • Haleon Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
  • Haleon Plc, Recent Deals Summary
Section 4 - Company’s Recent Developments
  • Aug 06, 2024: Haleon Announces Board Changes
  • May 01, 2024: Haleon PLC Announces Directorate Change
  • Apr 24, 2024: Haleon plc: Appointment of Dawn Allen as Chief Financial Officer
  • Feb 29, 2024: Haleon Reports 2023 Full Year Results
  • Jan 24, 2024: Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination
  • Aug 02, 2023: Haleon Announces 2023 Half-Year Results
  • Apr 20, 2023: Haleon PLC Results of Haleon 2023 Annual General Meeting
  • Mar 02, 2023: Haleon Reports 2022 Full year results
  • Jan 31, 2023: Haleon Announces Board changes
Section 5 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Haleon Plc, Key Facts
  • Haleon Plc, Key Employees
  • Haleon Plc, Key Employee Biographies
  • Haleon Plc, Major Products and Services
  • Haleon Plc, History
  • Haleon Plc, Other Locations
  • Haleon Plc, Subsidiaries
  • Haleon Plc, Key Competitors
  • Haleon Plc, Ratios based on current share price
  • Haleon Plc, Annual Ratios
  • Haleon Plc, Interim Ratios
  • Haleon Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Haleon Plc, Performance Chart (2019 - 2023)
  • Haleon Plc, Ratio Charts

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Colgate-Palmolive Co
  • Unilever Plc
  • Reckitt Benckiser Group Plc
  • Dabur India Ltd
  • Noevir Holdings Co Ltd